Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03754465 · ClinicalTrials.gov registry record · Phase 2
Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers
A Phase 2 study, sponsored by Anterogen Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT03754465: Completed Phase 2 study, sponsored by Anterogen Co..
NCT03754465 is a Phase 2 study that has completed, run by Anterogen Co.. The registered enrollment target is 66 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03754465, a Phase 2 study, has completed, sponsored by Anterogen Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is a phase 2 double-blind clinical study to evaluate the efficacy and Safety of ALLO-ASC-SHEET in subjects with Diabetic Foot Ulcers, compared to placebo therapy.
Primary Outcome
Proportions of subjects who achieved complete wound closure
Interventions
- BIOLOGICAL ALLO-ASC-DFU
- PROCEDURE Hydrogel SHEET(Vehicle control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2019-01-02 |
| Est. Completion | 2023-10-23 |
| Phase | Phase 2 |
What the finished NCT03754465 record still lists
NCT03754465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which ALLO-ASC-DFU is the first listed.
NCT03754465 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03754465 about?
NCT03754465 is a clinical study titled "Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers". This is a phase 2 double-blind clinical study to evaluate the efficacy and Safety of ALLO-ASC-SHEET in subjects with Diabetic Foot Ulcers, compared to placebo therapy.
What is the current status of trial NCT03754465?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2019-01-02. Estimated completion is 2023-10-23.
What interventions are being tested in trial NCT03754465?
The interventions under investigation include: ALLO-ASC-DFU (BIOLOGICAL), Hydrogel SHEET(Vehicle control) (PROCEDURE).
Who is sponsoring clinical trial NCT03754465?
This trial is sponsored by Anterogen Co., which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03754465's enrollment target sits among peer trials
66 975th of 2000 higher than 1,014 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI